The global neurotechnology market was valued at approximately USD 16.82 billion in 2025 and is projected to grow at a CAGR of 11.90% during the forecast period of 2026–2035, reaching a value of USD 51.78 billion by 2035. Neurotechnology, which involves the development and application of technologies for monitoring, treating, and enhancing the brain and nervous system, is witnessing significant growth. This market expansion is being driven by the increasing prevalence of neurological disorders, advancements in neurostimulation and brain-computer interface (BCI) technologies, and growing demand for innovative treatments in the healthcare sector.Key Drivers of Market Growth
Rising Incidence of Neurological Disorders
The growing prevalence of neurological conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis is one of the primary factors contributing to the growth of the neurotechnology market. As the global population ages, the incidence of age-related neurological diseases is on the rise, particularly in developed countries. For instance, the World Health Organization (WHO) estimates that the number of people living with dementia worldwide will reach 78 million by 2030, further driving demand for neurotechnology solutions that can aid in the diagnosis, management, and treatment of such conditions.
Get a Free Sample Report with Table of Contents: Click Here
Neurotechnology innovations, including neurostimulation devices and wearable EEG devices, are helping to manage the symptoms of neurological conditions and improve the quality of life for patients. As the number of individuals affected by neurological disorders continues to grow, the demand for advanced neurotechnology solutions will accelerate.
Technological Advancements in Neurostimulation and Brain-Computer Interfaces
Neurostimulation, which involves the use of electrical impulses to stimulate the brain or nervous system, has gained significant traction in the treatment of neurological disorders. Devices such as deep brain stimulators (DBS), transcranial magnetic stimulation (TMS) devices, and spinal cord stimulators are widely used for conditions like Parkinson’s disease, chronic pain, and depression. These devices are expected to witness increasing adoption due to advancements in technology, improved precision, and better patient outcomes.
Similarly, brain-computer interfaces (BCIs) are another rapidly advancing area in neurotechnology. BCIs enable direct communication between the brain and external devices, offering significant potential for individuals with severe neurological impairments, such as paralysis. As the technology continues to evolve, BCIs are expected to expand their applications beyond medical use, contributing to the overall growth of the neurotechnology market.
Growing Demand for Non-Invasive Neurological Monitoring
There is an increasing demand for non-invasive methods of monitoring brain function and neurological health. Wearable neurotechnology devices, such as EEG headsets and brain activity monitors, are gaining popularity among both healthcare professionals and consumers due to their ability to monitor brain health in real-time without the need for surgery or extensive medical procedures.